125 related articles for article (PubMed ID: 38476079)
1. A randomized double-blind pilot study to evaluate the efficacy, safety, and tolerability of intravenous iron versus oral iron for the treatment of restless legs syndrome in patients with iron deficiency anemia.
Short V; Allen R; Earley CJ; Bahrain H; Rineer S; Kashi K; Gerb J; Auerbach M
Am J Hematol; 2024 Jun; 99(6):1077-1083. PubMed ID: 38476079
[TBL] [Abstract][Full Text] [Related]
2. Iron for the treatment of restless legs syndrome.
Trotti LM; Becker LA
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD007834. PubMed ID: 30609006
[TBL] [Abstract][Full Text] [Related]
3. Randomized, placebo-controlled trial of ferric carboxymaltose in restless legs syndrome patients with iron deficiency anemia.
Bae H; Cho YW; Kim KT; Allen RP; Earley CJ
Sleep Med; 2021 Aug; 84():179-186. PubMed ID: 34157632
[TBL] [Abstract][Full Text] [Related]
4. Open-label study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome.
Schneider J; Krafft A; Manconi M; Hübner A; Baumann C; Werth E; Gyr T; Bassetti C
Sleep Med; 2015 Nov; 16(11):1342-1347. PubMed ID: 26498233
[TBL] [Abstract][Full Text] [Related]
5. Response to intravenous iron in patients with iron deficiency anemia (IDA) and restless leg syndrome (Willis-Ekbom disease).
Mehmood T; Auerbach M; Earley CJ; Allen RP
Sleep Med; 2014 Dec; 15(12):1473-6. PubMed ID: 25441748
[TBL] [Abstract][Full Text] [Related]
6. Ferric carboxymaltose effects on restless legs syndrome and on brain iron in patients with iron deficiency anemia.
Bae H; Cho YW; Kim KT; Li X; Earley CJ
Sleep Med; 2023 Sep; 109():128-131. PubMed ID: 37437492
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study.
Wang J; O'Reilly B; Venkataraman R; Mysliwiec V; Mysliwiec A
Sleep Med; 2009 Oct; 10(9):973-5. PubMed ID: 19230757
[TBL] [Abstract][Full Text] [Related]
8. Iron for restless legs syndrome.
Trotti LM; Bhadriraju S; Becker LA
Cochrane Database Syst Rev; 2012 May; 5(5):CD007834. PubMed ID: 22592724
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome.
Sloand JA; Shelly MA; Feigin A; Bernstein P; Monk RD
Am J Kidney Dis; 2004 Apr; 43(4):663-70. PubMed ID: 15042543
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Parenteral or Oral Iron Supplementation on Fatigue, Sleep, Quality of Life and Restless Legs Syndrome in Iron-Deficient Blood Donors: A Secondary Analysis of the IronWoMan RCT.
Macher S; Herster C; Holter M; Moritz M; Matzhold EM; Stojakovic T; Pieber TR; Schlenke P; Drexler C; Amrein K
Nutrients; 2020 May; 12(5):. PubMed ID: 32380660
[TBL] [Abstract][Full Text] [Related]
11. Does Improvement of Low Serum Ferritin Improve Symptoms of Restless Legs Syndrome in a Cohort of Pediatric Patients?
Rosen GM; Morrissette S; Larson A; Stading P; Barnes TL
J Clin Sleep Med; 2019 Aug; 15(8):1149-1154. PubMed ID: 31482837
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of ferric carboxymaltose treatment in patients with restless legs syndrome.
Cho YW; Allen RP; Earley CJ
Sleep Med; 2016 Sep; 25():16-23. PubMed ID: 27823710
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study.
Deng Y; Wu J; Jia Q
Med Sci Monit; 2017 Mar; 23():1254-1260. PubMed ID: 28285317
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome.
Davis BJ; Rajput A; Rajput ML; Aul EA; Eichhorn GR
Eur Neurol; 2000; 43(2):70-5. PubMed ID: 10686463
[TBL] [Abstract][Full Text] [Related]
15. Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension.
Trenkwalder C; Beneš H; Grote L; García-Borreguero D; Högl B; Hopp M; Bosse B; Oksche A; Reimer K; Winkelmann J; Allen RP; Kohnen R;
Lancet Neurol; 2013 Dec; 12(12):1141-50. PubMed ID: 24140442
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of ferric carboxymaltose (FCM) 500 mg dose for the treatment of Restless Legs Syndrome.
Cho YW; Allen RP; Earley CJ
Sleep Med; 2018 Feb; 42():7-12. PubMed ID: 29458749
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron.
Vadhan-Raj S; Strauss W; Ford D; Bernard K; Boccia R; Li J; Allen LF
Am J Hematol; 2014 Jan; 89(1):7-12. PubMed ID: 23983177
[TBL] [Abstract][Full Text] [Related]
18. The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia.
Allen RP; Auerbach S; Bahrain H; Auerbach M; Earley CJ
Am J Hematol; 2013 Apr; 88(4):261-4. PubMed ID: 23494945
[TBL] [Abstract][Full Text] [Related]
19. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.
Khalafallah AA; Hyppa A; Chuang A; Hanna F; Wilson E; Kwok C; Yan C; Gray Z; Mathew R; Falloon P; Dennis A; Pavlov T; Allen JC
Semin Hematol; 2018 Oct; 55(4):223-234. PubMed ID: 30502851
[TBL] [Abstract][Full Text] [Related]
20. How we diagnose and treat iron deficiency anemia.
Auerbach M; Adamson JW
Am J Hematol; 2016 Jan; 91(1):31-8. PubMed ID: 26408108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
